Vesalius Therapeutics, a company pioneering a revolutionary platform to deliver breakthrough treatments for common diseases, today announced a multi-target strategic alliance with GSK to discover and ...

LEMSIP and other popular cold and flu tablets should be pulled from Britain’s shelves because they don’t work, experts have ...

With over 23 years of experience in sales and marketing, Menon brings a wealth of expertise from his previous leadership roles at Flipkart, Hindustan Unilever Ltd, Glaxo SmithKline Consumer ... for ...

Along with GSK, Pfizer, Boehringer Ingelheim ... and independent laboratories shows that one ranitidine 300 mg tablet can contain tens of thousands of nanograms (ng) of NDMA, greatly exceeding ...

About GSK GSK is a global biopharma company with a purpose to unite ... Gan & Lee Pharmaceuticals Announced Positive Phase 1 Results for Its Oral GLP-1 Receptor Agonist GZR18 Tablet in Healthy ...

A higher incidence of asthma in South Africa is likely linked to high cases of bronchitis, according to the Clean Air Fund.

2024 /CNW/ - GSK announced today that Health Canada has approved Ojjaara (momelotinib) for the treatment of s... Gan & Lee Pharmaceuticals Announced Positive Phase 1 Results for Its Oral GLP-1 ...

Achieved $49.3 million in OGSIVEO® (nirogacestat) net product revenue in the third quarter - - Long-term follow-up data from the Phase 3 DeFi trial of nirogacestat in adults with desmoid tumors highli ...

GSK is the latest to turn its back on prominent industry lobbying group Biotechnology Innovation Organization (BIO), following a string of exits by companies including Pfizer, UCB, WuXi AppTec and ...

The FDA has started a review of Unicycive Therapeutics' drug for hyperphosphataemia in patients with chronic kidney disease ...